Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-0.08%-1.43%+15.87%+67.24% 47.71B
-3.21%+1.37%+51.19%+124.26% 40.3B
-0.40%-1.23%-10.08%+17.30% 12.09B
+1.11%-1.34%+13.27%+72.07% 11.68B
+0.19%+0.58%+30.98%+151.21% 9.19B
-0.39%-0.92%+20.49%+39.85% 7.57B
-1.35%+0.74%+47.38%-12.13% 7.24B
-0.64%-0.02%+19.65%+205.39% 6.84B
-5.36%-6.36%-38.04%+19.49% 5.42B
Average +17,988.99%-1.11%+16.75%+76.07% 16.45B
Weighted average by Cap. -0.94%-0.57%+24.08%+83.63%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock